XML 61 R32.htm IDEA: XBRL DOCUMENT v3.19.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2017
Income Tax Disclosure [Abstract]  
Schedule of Expense (Benefit) for Income Taxes
Income tax expense (benefit) was as follows:
(in thousands)
 
For the Year Ended December 31,
 
 
2017
 
2016
 
2015 (Restated)
 
2014 (Restated)
Current tax expense (benefit):
 
 
 
 
 
 
 
 
Federal
 
$
127

 
$
(6,568
)
 
$
(859
)
 
$
7,476

State
 
77

 
60

 
215

 
1,892

Total
 
$
204

 
$
(6,508
)
 
$
(644
)
 
$
9,368

 
 
 
 
 
 
 
 
 
Deferred tax expense (benefit)
 
 
 
 
 
 
 
 
Federal
 
$
100

 
$
13,907

 
$
(6,713
)
 
$
(1,183
)
State
 
139

 
4,214

 
(2,345
)
 
(441
)
         Total deferred tax expense (benefit)
 
239

 
18,121

 
(9,058
)
 
(1,624
)
Total tax expense (benefit)
 
$
443

 
$
11,613

 
$
(9,702
)
 
$
7,744

Reconciliation of Effective Tax Rate to the Statutory Rate
A reconciliation between the Company’s effective tax rate on (loss) income before income taxes and the statutory tax rate was as follows: 
(in thousands)
 
For the Year Ended December 31,
 
 
2017
 
2016
 
2015 (Restated)
 
2014 (Restated)
 
 
Amount
 
Percent
 
Amount
 
Percent
 
Amount
 
Percent
 
Amount
 
Percent
Income tax (benefit) expense at federal statutory rate
 
$
(16,037
)
 
34.0
 %
 
$
(12,192
)
 
34.0
 %
 
$
(4,282
)
 
34.0
 %
 
$
9,935

 
34.0
 %
State income tax, net of federal benefit
 
(2,283
)
 
4.8
 %
 
(1,758
)
 
4.9
 %
 
(1,101
)
 
8.7
 %
 
1,295

 
4.4
 %
Non-deductible warrants (income)/expense
 
1,360

 
(2.9
)%
 
(481
)
 
1.3
 %
 
(3,162
)
 
25.1
 %
 
(2,098
)
 
(7.2
)%
Domestic production activity
 

 
 %
 

 
 %
 

 
 %
 
(334
)
 
(1.1
)%
Other permanent differences
 
106

 
(0.2
)%
 
110

 
(0.3
)%
 
137

 
(1.1
)%
 
191

 
0.7
 %
Research and development tax credits
 
(426
)
 
0.9
 %
 
(837
)
 
2.3
 %
 
(1,632
)
 
13.0
 %
 
(1,953
)
 
(6.7
)%
Tax reserve reassessment
 
104

 
(0.2
)%
 
(141
)
 
0.4
 %
 
412

 
(3.3
)%
 
246

 
0.8
 %
Federal tax rate change
 
10,899

 
(23.1
)%
 

 
 %
 

 
 %
 

 
 %
Change in valuation allowance
 
4,956

 
(10.4
)%
 
26,846

 
(74.9
)%
 

 
 %
 

 
 %
3PI Settlement
 
1,976

 
(4.2
)%
 

 
 %
 

 
 %
 

 
 %
Other, net
 
(212
)
 
0.4
 %
 
66

 
(0.1
)%
 
(74
)
 
0.6
 %
 
462

 
1.6
 %
Income tax expense (benefit)
 
$
443

 
(0.9
)%
 
$
11,613

 
(32.4
)%
 
$
(9,702
)
 
77.0
 %
 
$
7,744

 
26.5
 %
Schedule of Significant Components of the Deferred Income Tax Assets and Liabilities
Significant components of deferred income tax assets and liabilities consisted of the following:
(in thousands)
 
As of December 31,
 
 
2017
 
2016
 
2015 (Restated)
 
2014 (Restated)
Deferred tax assets:
 
 
 
 
 
 
 
 
Net operating loss carryforwards
 
$
15,399

 
$
1,154

 
$
66

 
$

Research and development credits
 
2,806

 
2,118

 
139

 

Other state credits
 
989

 
407

 
164

 

Inventory
 
2,560

 
5,837

 
5,094

 
3,035

Allowances and bad debts
 
596

 
501

 
334

 
119

Accrued warranty
 
3,387

 
3,820

 
1,413

 
948

Accrued wages and benefits
 
351

 
786

 
893

 
917

Stock-based compensation
 
645

 
1,021

 
756

 
576

Capitalized research and development costs
 
1,090

 
2,291

 
2,617

 
2,316

Intangible amortization
 
1,734

 
4,519

 
4,311

 

Other
 
3,397

 
6,638

 
5,069

 
3,615

Total deferred tax assets
 
32,954

 
29,092

 
20,856

 
11,526

         Valuation allowance
 
(31,992
)
 
(26,847
)
 

 

Total deferred tax assets, net of valuation allowance
 
$
962

 
$
2,245

 
$
20,856

 
$
11,526

 
 
 
 
 
 
 
 
 
Deferred tax liabilities:
 
 
 
 
 
 
 
 
Intangible amortization
 
$

 
$

 
$

 
$
(1,091
)
Tax depreciation in excess of book depreciation on property, plant and equipment
 
(1,665
)
 
(2,709
)
 
(3,199
)
 
(1,870
)
Total deferred tax liabilities
 
$
(1,665
)
 
$
(2,709
)
 
$
(3,199
)
 
$
(2,961
)
 
 
 
 
 
 
 
 
 
Net deferred tax (liability) asset
 
$
(703
)
 
$
(464
)
 
$
17,657

 
$
8,565


The Company’s net deferred tax assets and liabilities are presented as follows in the Consolidated Balance Sheets:
(in thousands)
 
As of December 31,
 
 
2017
 
2016
 
2015 (Restated)
 
2014 (Restated)
Current deferred tax assets, net
 
$

 
$

 
$

 
$
8,552

Non-current deferred tax asset/(liabilities), net
 
(703
)
 
(464
)
 
17,657

 
13

Net deferred tax (liability) asset
 
$
(703
)
 
$
(464
)
 
$
17,657

 
$
8,565

Schedule of the Change in Unrecognized Tax Benefits
The change in unrecognized tax benefits excluding interest and penalties were as follows:
(in thousands)
 
For the Year Ended December 31,
 
 
2017
 
2016
 
2015
 
2014
Unrecognized Tax Benefits Excluding Interest and Penalties
 
 
 
 
 
(Restated)
 
(Restated)
Balance at beginning of year
 
$
1,202

 
$
1,338

 
$
894

 
$
614

Additions based on tax positions related to the current year
 
105

 
168

 
525

 
373

Additions/(reductions) for tax positions of prior years
 

 
(304
)
 
(81
)
 
(93
)
Balance at end of year
 
$
1,307

 
$
1,202

 
$
1,338

 
$
894

Summary of Income Tax Examinations
With few exceptions, the major jurisdictions subject to examination by the relevant tax authorities and open tax years, stated as the Company’s fiscal years, are as follows:
Jurisdiction
Open Tax Years
U.S. Federal
2014
-
2017
U.S. States
2013
-
2017